{"id":42839,"date":"2023-11-20T02:55:05","date_gmt":"2023-11-20T08:55:05","guid":{"rendered":"https:\/\/stage.cancerimagingarchive.net\/tcia-citation\/ispy1-pub\/"},"modified":"2023-11-20T02:55:05","modified_gmt":"2023-11-20T08:55:05","slug":"ispy1-pub","status":"publish","type":"tcia_citation","link":"https:\/\/stage.cancerimagingarchive.net\/tcia-citation\/ispy1-pub\/","title":{"rendered":"ISPY1-PUB"},"template":"","class_list":["post-42839","tcia_citation","type-tcia_citation","status-publish"],"tcia_citation_type":"Publication Citation","tcia_citation_text":"<p><span>Hylton, N. M., Gatsonis, C. A., Rosen, M. A., Lehman, C. D., Newitt, D. C., Partridge, S. C., Bernreuter, W. K., Pisano, E. D., Morris, E. A., Weatherall, P. T., Polin, S. M., Newstead, G. M., Marques, H. S., Esserman, L. J., &amp; Schnall, M. D. (2016). <strong>Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival\u2014Results from the ACRIN 6657\/CALGB 150007 I-SPY 1 TRIAL.<\/strong> In Radiology (Vol. 279, Issue 1, pp. 44\u201355). Radiological Society of North America (RSNA). <a href=\"https:\/\/doi.org\/10.1148\/radiol.2015150013\">https:\/\/doi.org\/10.1148\/radiol.2015150013<\/a><\/span><\/p>\n","tcia_citation_statement":"","tcia_citation_doi":"10.1148\/radiol.2015150013","_links":{"self":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/v1\/citations\/42839","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/v1\/citations"}],"about":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/wp\/v2\/types\/tcia_citation"}],"wp:attachment":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/wp\/v2\/media?parent=42839"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}